Lonza collaborates with Oxford Nanopore to accelerate mRNA technology
Swiss contract drug manufacturer Lonza has partnered with Oxford Nanopore to enhance the analysis of mRNA products.
Stay updated with breaking news from Rna Capabilities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss contract drug manufacturer Lonza has partnered with Oxford Nanopore to enhance the analysis of mRNA products.
We took the time to speak with Amy Walker, VP of research, at biotechnology company 4basebio to discuss if synthetic DNA templates represent the future of mRNA production.
Providence Therapeutics, a biopharmaceutical company developing mRNA vaccines and therapeutics, has announced its partnership with University Health Network (UHN).
Providence Therapeutics, a biopharmaceutical company developing mRNA vaccines and therapeutics, has announced its partnership with with University Health Network (UHN).
MRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers, according to a new report by science and technology company Merck.